Call Us: Email: novopept@gmail.com
enLanguage
Ozenoxacin CAS 245765-41-7

Ozenoxacin CAS 245765-41-7

What Is Ozenoxacin ? Ozenoxacin is a novel, non-fluorinated quinolone antibiotic API developed exclusively for topical dermatological applications . Unlike traditional fluoroquinolones, Ozenoxacin does not contain a fluorine atom , resulting in an improved safety profile and negligible systemic...

What Is Ozenoxacin?

 

Ozenoxacin is a novel, non-fluorinated quinolone antibiotic API developed exclusively for topical dermatological applications. Unlike traditional fluoroquinolones, Ozenoxacin does not contain a fluorine atom, resulting in an improved safety profile and negligible systemic absorption.

As a professional Ozenoxacin API manufacturer and supplier, we provide ≥99.0% purity pharmaceutical-grade Ozenoxacin suitable for the development of topical creams, ointments, and dermatological formulations. Full regulatory documentation (COA, MSDS, DMF upon request) is available to support global registrations.

 

API Category: Topical Antibiotics
Dosage Form Compatibility: Creams, ointments, gels

 

Item

Specification

Product Name

Ozenoxacin

CAS Number

245765-41-7

Chemical Name

1-cyclopropyl-8-methyl-7-(5-methylpyridin-3-yl)-4-oxoquinoline-3-carboxylic acid

Molecular Formula

C₂₁H₂₁N₃O₃

Molecular Weight

363.42 g/mol

Appearance

Crystalline powder

Purity (HPLC)

≥99.0%

Quality Standard

In-house / GMP

Documentation

COA, MSDS, DMF available

 

Key Advantages of Ozenoxacin

 

  • Non-fluorinated quinolone with enhanced safety profile
  • High potency against Gram-positive pathogens, including MRSA
  • Negligible systemic absorption, ideal for topical use
  • Low resistance potential compared with older topical antibiotics
  • Short treatment duration, improving patient compliance

 

Mechanism of Action (MOA)

 

Ozenoxacin exhibits rapid bactericidal activity through a unique dual-target mechanism, setting it apart from traditional topical antibiotics.

How Ozenoxacin Works:

Dual Enzyme Inhibition: Simultaneously inhibits DNA gyrase and topoisomerase IV, both essential for bacterial DNA replication and repair

Resistance Avoidance: Effectively bypasses common bacterial efflux pumps that limit the efficacy of other quinolones

High Bactericidal Potency: Demonstrates strong activity against Staphylococcus aureus, Streptococcus pyogenes, and MRSA

 

 

What Is Ozenoxacin Used For?

 

 

The primary clinical indication for Ozenoxacin is the treatment of impetigo, a highly contagious superficial bacterial skin infection.

Clinical Applications:

  1. Indication: Impetigo
  2. Target Pathogens:
  3. Staphylococcus aureus
  4. Streptococcus pyogenes
  5. Patient Population: Approved for adults and pediatric patients ≥2 months old
  6. Topical Safety: Remains localized in the epidermis and stratum corneum, minimizing systemic exposure

 

Ozenoxacin API

 

What Are the Common Side Effects of Ozenoxacin?

 

Ozenoxacin is generally well tolerated. Reported side effects are localized and mild, including:

  • Application-site irritation or erythema
  • Rare cases of seborrheic dermatitis or rosacea

Due to minimal systemic absorption, systemic adverse effects such as nausea or dizziness are uncommon. 

 

Ozenoxacin vs. Mupirocin

 

While Mupirocin has long been considered a standard topical antibiotic, Ozenoxacin represents a next-generation alternative with several clinical and technical advantages.

Feature Ozenoxacin API Mupirocin
Drug Class Non-fluorinated quinolone Pseudomonic acid derivative
Mechanism DNA gyrase & Topo IV inhibition Protein synthesis inhibition
Speed of Action Rapid (clinical response often within 2 days) Moderate
Treatment Duration 5 days (2× daily) 7–10 days (3× daily)
MRSA Activity High potency Effective but resistance increasing
Resistance Risk Low Increasing globally
Systemic Absorption Negligible Minimal but higher than Ozenoxacin
Patient Compliance High Moderate

 

Conclusion :
Ozenoxacin offers superior compliance, potency, and resistance control, making it a premium choice for modern topical antibiotic formulations.

 

 

 

Message us to get your personalized quotation within 24 hours.

 

  • Whatsapp:+852 6736 4057

  • Telegram:@hinovopept

  • Email:novopept@gmail.com

novopept contact

 

Hot Tags: ozenoxacin cas 245765-41-7, China ozenoxacin cas 245765-41-7 manufacturers, suppliers, factory

Send Inquiry

(0/10)

clearall